wada aod9604 prohibited list status 2025 The of Substances: What You Need to Know Frontiers | Illegal and falsified

Phase 4: AOD 9604 cycle break (week 17+) After 12-16 weeks of AOD 9604, discontinue it for a 4-week break while continuing tirzepatide

Mild pain at injection site A minor side effect is mild pain in the region where the injection was administered

AOD-9604 Dosage Protocols AOD-9604 is typically administered via subcutaneous injection, though compounded versions in capsules or troches also exist

Itching or swelling around the injection area

However, after prolonged heat exposure, strenuous physical activity, or excessive sweating, your body may also need to replace important electrolytes and nutrients that were lost

doi: 10.1016/j.foodchem.2024.140849